BRIEF-Teva Pharmaceutical reaffirms 2013 outlook

Thu Feb 7, 2013 8:39am EST

Feb 7 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says:

* Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video